Getting the right surge protector for the situation is important. Our buying guide will point you in the right direction.

More than $500 million of the share sales took place this month as the California-based chip designer's share price climbed to an all-time high, the report said. Jensen Huang, Nvidia's chief ...

Nvidia insiders sold over $1 billion worth of company stock in the past year, with a notable uptick in recent trading activity as execs capitalize on surging investor interest in AI.

Global oil benchmark Brent crude climbed 1.21 per cent to USD 67.95 a barrel. Foreign Institutional Investors offloaded equities worth ₹ 5,266.01 crore on Tuesday, according to exchange data.

Griffin is the highest-rated commit in Alabama's 2026 class and second Top247 five-star prospect in the group ...

In a strategic move to strengthen the resilience of its infrastructure, Manila Water is investing ₱158.16 million in a comprehensive lightning and surge protection project across eight key ...

Nvidia’s stock hit a record on Wednesday, and the chipmaker reclaimed the crown as the world’s most valuable company after an analyst said the chipmaker was set to ride a “Golden Wave” of ...

The gold August futures settled at Rs 1,00,276 per 10 grams, showing a 1.91% increase, whilst silver July futures concluded at Rs 1,06,493 per kilogram, registering a 0.57% gain.

Nvidia insiders sold over $1 billion in stock amid market surge, FT reports More than $500 million of the share sales took place this month Published: Sun 29 Jun 2025, 7:52 PM By: Reuters ...

We conducted a phase 1–2 study of zimislecel in persons with type 1 diabetes. In part A, participants received a half dose of zimislecel (0.4×10 9 cells) as a single infusion into the portal ...

Shares of Bharat Dynamics experienced a notable surge of 1.39% during today's trading session, reaching Rs 1928.50, driven by high trading volumes as of 11:29 am.

Key takeaways: Zimislecel is an investigational stem cell-derived islet therapy for type 1 diabetes. Ten of 12 participants no longer required insulin at 1 year. Results from this phase 1/2 study ...